KMHH-03

N/A

Report date: 2023/01/02 17:06:07
NME

Base Information

Drug NameKMHH-03
Drug Alias NameKMHH-03KMHH03
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionHeat Shock Protein 90 Beta Family Member 1 inhibitorsReceptor protein-tyrosine kinase erbB-2 antagonistsUrokinase plasminogen activator surface receptor degraders
TargetsHeat Shock Protein 90 Beta Family Member 1Receptor protein-tyrosine kinase erbB-2Urokinase plasminogen activator surface receptor
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBeijing Kangming Haihui Biological Technology Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesN/A
Inactive CompaniesBeijing Kangming Haihui Biological Technology Co Ltd
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A